8-K
Current Report
X4 Pharmaceuticals, Inc Filed Acc 0001628280-21-005139
Material agreement · New debt or obligation · Unregistered share sale · Other events
- Item 1.01 Entry into a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
- Item 3.02 Unregistered sales of equity securities
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading xfor-20210318.htm…